Literature DB >> 19479590

The motivations for participation in public-private partnerships for the provision of tuberculosis treatment in South Africa.

Edina Sinanovic1, Lilani Kumaranayake.   

Abstract

There is increasing interest in public-private partnerships (PPPs) generally, and more specifically for the provision of tuberculosis (TB) treatment, yet little is known about the motivations for such partnerships and the nature of the incentives that are required to achieve a desirable outcome of the partnerships. Using the new institutional economics approach, this study examines the motivations for participation in existing and potential models of PPPs for the provision of TB treatment in South Africa. Fourteen semi-structured interviews were conducted with private providers and government officials. Both current and potential private partners were interviewed. The study found that private providers in existing and potential partnerships appear to have both financial and non-financial motivations for participation in partnership for the provision of TB. For a partnership to be successful, in addition to sufficient motivation, the level of competition between private providers, regulatory framework, and social and political awareness becomes increasingly important.

Entities:  

Mesh:

Year:  2010        PMID: 19479590     DOI: 10.1080/17441690902942498

Source DB:  PubMed          Journal:  Glob Public Health        ISSN: 1744-1692


  3 in total

Review 1.  From habits of attrition to modes of inclusion: enhancing the role of private practitioners in routine disease surveillance.

Authors:  Revati K Phalkey; Carsten Butsch; Kristine Belesova; Marieke Kroll; Frauke Kraas
Journal:  BMC Health Serv Res       Date:  2017-08-25       Impact factor: 2.655

2.  Exploring the roots of antagony in the safe male circumcision partnership in Botswana.

Authors:  Masego Katisi; Marguerite Daniel
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

3.  The case for stronger regulation of private practitioners to control tuberculosis in low- and middle-income countries.

Authors:  Yodi Mahendradhata
Journal:  BMC Res Notes       Date:  2015-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.